Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mehmet Ali Nahit Şendur (Mehmet An Sendur, Mehmet Ali Sendur)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Metastatic Colorectal Cancer

Top Venues

Future oncology (London, England)

Journal of gastrointestinal cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Saadettin Kılıçkap, Sertac Ak, Oldac U Dursun, Mehmet Ali Nahit Şendur, Nuri Karadurmus, Umut Demirci
Safety of lorlatinib in ALK-positive non-small-cell lung cancer and management of central nervous system adverse events. Future oncology (London, England) (2023)
Irfan Cicin, Nuri Karadurmus, Ahmet Bilici, Taha Bahsi, Mehmet Ali Nahit Şendur, Umut Demirci, Sema Sezgin Goksu, Ozlem Er, Serdar Ceylaner, Ozge Fulya Ozturk Saglam, Birkan Aver, Saadettin Kılıçkap
Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye. Future oncology (London, England) (2023)
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray, Suleyman Sahin, Teoman Sakalar, Cihan Erol, Mehmet Ali Nahit Şendur, Ahmet Bilgehan Şahin, Erdem Cubukcu, Deniz Can Guven, Saadettin Kılıçkap, Yakup Ergün, Doğan Uncu, Nazım Serdar Turhal, Necdet Üskent, Havva Yeşil Çinkir, Atakan Demir, Ramazan Acar, Nuri Karadurmus, Sema Türker, Mustafa Altınbaş, Mert Karaoğlan, Filiz Çay Şenler
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group. Journal of gastrointestinal cancer (2021)